Education
About Us
Working with TipRanks
Follow Us
Cartesian Therapeutics, Inc. (RNAC)
NASDAQ:RNAC
Technical Sentiment
Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cartesian Therapeutics, Inc.’s (RNAC) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting Cartesian Therapeutics, Inc. is a Buy.
Cartesian Therapeutics, Inc.’s (RNAC) 20-Day exponential moving average is 7.01, while Cartesian Therapeutics, Inc.’s (RNAC) share price is $6.5, making it a Sell.
Cartesian Therapeutics, Inc.’s (RNAC) 50-Day exponential moving average is 7.37, while Cartesian Therapeutics, Inc.’s (RNAC) share price is $6.5, making it a Sell.
Cartesian Therapeutics (RNAC) Pivot Points
Classic
5.93
6.10
6.30
6.47
6.67
6.84
7.04
Fibonacci
6.10
6.24
6.33
6.47
6.61
6.70
6.84
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Cartesian Therapeutics (RNAC) Moving Averages
MA5
6.61Sell
6.60Sell
MA10
6.83Sell
6.79Sell
MA20
7.17Sell
7.01Sell
MA50
7.27Sell
7.37Sell
MA100
8.03Sell
8.15Sell
MA200
9.53Sell
9.85Sell
Cartesian Therapeutics, Inc.’s (RNAC) 10-Day exponential moving average is 6.79, while Cartesian Therapeutics, Inc.’s (RNAC) share price is $6.5, making it a Sell.
Cartesian Therapeutics, Inc.’s (RNAC) 100-Day exponential moving average is 8.15, while Cartesian Therapeutics, Inc.’s (RNAC) share price is $6.5, making it a Sell.
Cartesian Therapeutics, Inc.’s (RNAC) stock price is $6.5 and Cartesian Therapeutics, Inc.’s (RNAC) 50-day simple moving average is 7.27, creating a Sell signal.
Cartesian Therapeutics, Inc.’s (RNAC) stock price is $6.5 and Cartesian Therapeutics, Inc.’s (RNAC) 100-day simple moving average is 8.03, creating a Sell signal.
Cartesian Therapeutics, Inc.’s (RNAC) stock price is $6.5 and Cartesian Therapeutics, Inc.’s (RNAC) 200-day simple moving average is 9.53, creating a Sell signal.
Cartesian Therapeutics (RNAC) Technical Indicators
RSI (14)
39.43
Neutral
STOCH (9,6)
10.15
Buy
STOCHRSI (14)
9.77
Buy
MACD (12,26)
-0.24
Buy
ADX (14)
10.29
Buy
Williams %R
-83.73
Buy
CCI (14)
-148.40
Buy
ATR (14)
0.49
-
Ultimate Oscillator
37.12
Neutral
ROC
-10.10
Sell
Cartesian Therapeutics, Inc.’s (RNAC) Relative Strength Index (RSI) is 39.43, creating a Neutral signal.
Cartesian Therapeutics, Inc.’s (RNAC) Trend Strength Indicator (ADX) is 10.29, creating a Buy signal.
Cartesian Therapeutics, Inc.’s (RNAC) Commodity Channel Index (CCI) is -148.40, creating a Buy signal.
Cartesian Therapeutics, Inc.’s (RNAC) Price Rate of Change (ROC) is -10.10, creating a Sell signal.
FAQ
Is RNAC a Buy, Hold, or Sell?
Based on RNAC’s technical indicators, RNAC is a Sell.
What is RNAC’s RSI (14)?
RNAC’s RSI (14) is 39.43, which suggests RNAC is a Neutral.
What is RNAC’s MACD?
RNAC’s MACD is -0.24, which suggests RNAC is a Buy.
What is RNAC’s 5-day moving average?
RNAC’s 5-day moving average is 6.61, which suggests RNAC is a Sell.
What is RNAC’s 20-day moving average?
RNAC 20-day moving average is 7.17, which suggests RNAC is a Sell.
What is RNAC’s 50-day moving average?
RNAC’s 50-day moving average is 7.27, which suggests RNAC is a Sell.
What is RNAC’s 200-day moving average?
RNAC’s 200-day moving average is 9.53, which suggests RNAC is a Sell.
What is RNAC’s Williams % R (14)?
RNAC’s Williams % R (14) is -83.73, which suggests RNAC is a Buy.
What is RNAC’s CCI (14)?
RNAC’s CCI (14) is -148.40, which suggests RNAC is a Buy.